Capsular contracture: causes, grading, and treatment options
What is capsular contracture? Capsular contracture is the most common long-term ...
Last Updated: August 4, 2026
Key takeaways
Capsular contracture happens when the scar tissue capsule around a breast implant tightens abnormally, causing firmness, pain, and visible distortion.
The Baker scale grades severity from I to IV, and Grades III and IV usually call for capsulectomy or capsulotomy.
Biofilm from subclinical bacterial contamination is one of the leading suspected causes, alongside chronic inflammation from the foreign body response.
Submuscular placement and antibiotic pocket irrigation are among the most consistently supported ways to lower the risk.
Practice management software like Pabau automates the follow-up schedule, so early grade progression is caught inside the highest-risk window.
What is capsular contracture?
Capsular contracture is the most common long-term complication after breast implant surgery. Many patients only hear the term once symptoms appear. When an implant is placed, the immune system forms a fibrous scar tissue capsule around it. That response is normal. In some patients the capsule tightens and hardens, compressing the implant and causing pain or distortion.
For cosmetic surgery and plastic surgery practices, the detail matters in pre-operative counseling, post-operative monitoring, and the documentation that follows a complication. This guide covers the definition, Baker grading, causes, diagnosis, treatment, and prevention. It also covers the workflows that catch progression early.
How capsular contracture develops: the pathophysiology
Any implant placed inside the body triggers an immune response. Fibroblasts migrate to the site and lay down collagen, forming the periprosthetic capsule within days of surgery. For most patients that capsule stays thin, pliable, and symptom-free.
Why the capsule contracts in only a subset of patients is still unsettled. A 2021 review in PubMed Central sets out two competing explanations. Biofilm is one of the leading hypotheses.
Under that model, subclinical bacterial contamination during placement seeds a low-grade film on the implant surface. The persistent microbial presence keeps inflammatory signaling switched on, driving myofibroblast activation and progressive capsular fibrosis. The competing explanation is chronic inflammation from the foreign body response itself, with no infection involved.
Two further factors feed into both models. Certain implant surface textures appear to amplify the fibrotic response. Hematoma or seroma in the early post-operative period creates an environment that accelerates capsule thickening. These pathways are what modern prevention targets, from antibiotic irrigation to implant selection.
Symptoms of capsular contracture
Symptoms track the Baker grades closely. Early capsular contracture is often undetectable. Later stages are visually obvious and frequently painful. Build each of the signs below into a standard post-operative checklist, whether it lives on paper or inside your med spa software.
- Breast firmness: the earliest detectable sign, felt as a breast that is harder than normal on palpation
- Tightness or pressure: patients often describe a squeezing sensation around the implant
- Visible shape change: the breast looks rounder, higher-riding, or asymmetric next to the other side
- Pain or tenderness: anything from mild discomfort to chronic pain, often worse with pressure or movement
- Implant displacement: in severe cases the implant visibly shifts from its original position
The American Society of Plastic Surgeons (ASPS) reports that roughly 75% of capsular contractures appear within two years of implant placement. That two-year window is where structured follow-up earns its keep.
The Baker grading scale
The Baker classification dates from the 1970s and is still the clinical standard. It grades capsular contracture across four levels, using breast appearance, texture, and patient symptoms. Grades I and II are usually managed conservatively. Grades III and IV point to surgery.
Baker grading is a clinical assessment rather than an imaging diagnosis. The grade written in the chart is therefore the record. Capturing it in a structured patient record at every post-operative visit builds the longitudinal picture that treatment decisions rest on.
Causes and risk factors
No single factor explains every case. The evidence points to a cluster of modifiable and non-modifiable contributors. That is why risk conversations with patients need to be specific rather than generic.
- Biofilm contamination: bacterial contamination during surgery colonizes the implant surface and triggers persistent low-grade inflammation
- Implant surface texture: textured implants have shown higher rates in some studies and lower rates in others. The 2019 recall of Allergan Biocell textured implants, driven by BIA-ALCL risk, moved many practices toward smooth devices.
- Implant placement plane: subglandular placement above the muscle is generally associated with higher rates than submuscular placement
- Post-operative hematoma or seroma: blood or fluid around the implant creates a pro-inflammatory environment in the critical early weeks
- Radiation therapy: reconstruction patients who receive radiation after mastectomy face substantially elevated risk, since radiation accelerates fibrosis in surrounding tissue
- Genetic predisposition: some patients appear intrinsically more prone to fibrotic responses, and keloid formers may carry elevated risk
- Prior capsular contracture: a patient who has had one episode is at increased risk with subsequent implants
Record these factors in the pre-operative note so post-operative monitoring can be calibrated per patient. That record is what makes patient care management after cosmetic surgery consistent from one patient to the next.
Diagnosing capsular contracture
Diagnosis is clinical. The surgeon palpates the breast to assess firmness, then assigns a Baker grade from physical findings and patient-reported symptoms. No imaging is needed to diagnose capsular contracture itself.
Imaging matters for ruling out the differential. Ultrasound confirms implant integrity and excludes seroma or hematoma. MRI is the gold standard for detecting silicone implant rupture. It is worth requesting when Grade III or IV contracture arrives with unusual symptoms.
One distinction matters for reconstruction patients. Baker Grade III to IV contracture with a periprosthetic effusion requires exclusion of BIA-ALCL, or breast implant-associated anaplastic large cell lymphoma. This Breastcancer.org resource walks through the diagnostic pathway for patients facing that question.
Consistent documentation at every follow-up is what makes progression visible. Recording Baker grade, symptom timeline, and imaging findings in one place lets the team compare visits objectively. Practice management software like Pabau holds that history together, and its digital consent forms sit in the same record.
Pro Tip
Document the Baker grade at every post-operative appointment, not only when symptoms worsen. A move from Grade I to Grade II over three months is clinically significant before the patient reports any pain. It also gives your surgical team earlier decision-making data.
Treatment options for capsular contracture
Treatment depends on Baker grade, symptoms, and whether the implant is still intact. Grade I and mild Grade II cases are often observed. Grade III and every Grade IV case usually needs surgical correction.
Non-surgical approaches
For Grade II contracture, some surgeons recommend implant displacement massage. The patient moves the implant inside its pocket to mechanically disrupt early capsule thickening. The evidence is mixed. Some surgeons report good outcomes with early massage protocols and others see no difference. Present it as an option some surgeons favor, not a proven standalone treatment.
Montelukast, sold as Singulair, is a leukotriene receptor antagonist used mainly in asthma. It has been investigated off-label as an adjunct for capsular contracture. Small studies suggest it may soften Grade II to III contracture in some patients, but the evidence is limited. It is not a standard or approved treatment here.
Any off-label use needs individual clinical judgment and an honest conversation about the evidence. Clinicians building personalized treatment plans should record the rationale in the note whenever they prescribe montelukast for this indication.
Capsulectomy vs capsulotomy
Two surgical procedures address capsular contracture directly, and severity decides between them. Capsulotomy releases the capsule and capsulectomy removes it. The condition of the implant and the surgeon’s own assessment also weigh in.
Capsular contracture can recur after surgery, and recurrence is well documented in the literature. Counsel patients on that before any corrective procedure. Corrective surgery is also coded separately from the original augmentation, 19325, so the operative note must make clear which procedure was performed.
For practices managing post-surgical follow-up, automated post-care emails can carry the schedule after a capsulectomy without anyone chasing it by hand.
How to reduce capsular contracture risk
No strategy removes the risk entirely. Several approaches show up consistently in the literature as risk-reducers, and they belong in a written protocol rather than in one surgeon’s memory.
- Antibiotic pocket irrigation: irrigating the implant pocket with a triple-antibiotic solution before placement reduces bacterial contamination. It is one of the best-supported prevention steps in the literature.
- Implant choice: many surgeons moved to smooth implants after the 2019 concerns about textured devices, though evidence comparing contracture rates by surface remains mixed
- Submuscular placement: placing the implant under the pectoralis major is associated with lower rates in most studies. The benefit varies with patient anatomy and implant type.
- Hematoma control: meticulous hemostasis, drains where appropriate, and stopping blood thinners pre-operatively all reduce post-operative fluid collection
- No-touch technique: minimizing implant handling and skin contact during insertion lowers the risk of transferring bacteria to the surface
- Early massage in selected patients: some surgeons recommend displacement massage after smooth implant placement, though the evidence is mixed and the protocol should be individualized
Recording which prevention protocol was followed during surgery creates an auditable trail. That trail supports clinical governance and any later medico-legal review. It is the same reason med spa compliance work starts with documentation.
How practice management software supports capsular contracture monitoring
Knowing the Baker grades and treatment options is one half of the job. The other half is operational. Every post-augmentation patient has to come back for follow-up, and their symptoms have to be captured the same way each time.
Practice management software supports that in three places along the patient journey. Bank MediSpa moved to digital patient records for the same reason, so the team can reach a patient’s history from anywhere.
Automated recall and follow-up reminders
Most capsular contractures develop within two years of surgery, which makes those two years the highest-risk window. Pabau’s automated patient workflows schedule recalls at six weeks, three months, six months, and 12 months after surgery. Missed appointments trigger follow-up prompts automatically, so early Grade II progression is less likely to slip past.
Before-and-after photo documentation
Visible shape change is a key Grade III indicator, and palpation alone can miss it early. Consistent before-and-after photo tracking at each follow-up builds a chronological visual record. Pabau’s photo progress tracking stores those images beside the clinical notes, so grade progression shows up in context.
Digital consent and post-operative care forms
Consent for breast augmentation should name capsular contracture directly. Cover the definition, the Baker scale, the chance of revision surgery, and the recurrence risk after correction. A procedure-specific medical consent form removes the ambiguity that generic documents leave behind.
Post-operative care instructions can carry symptom check-in prompts as well, so patients know what to report and when.
Manage post-operative follow-up without the admin overhead
Pabau automates patient reminders, tracks clinical progress notes, and keeps post-augmentation documentation in one place. Your team spends less time on paperwork and more time catching complications early.
Conclusion
Capsular contracture is not fully preventable, so the win is in catching it early. A Grade II found at a three-month check is a conversation. The same case found at two years is usually an operation.
That makes the follow-up schedule the part of the pathway most worth fixing. Pre-operative counseling sets the expectation, consistent Baker grading records the change, and automated recalls make sure someone is looking. Book a demo to see how Pabau keeps follow-up, grading, and photo records in one place.
Continue your research
Planning a new cosmetic surgery practice? Opening a cosmetic surgery clinic covers the operational foundations a new practice needs to get right.
Billing a revision after capsulectomy? 19380 breaks down the coding and documentation for revising a reconstructed breast.
Placing tissue expanders in reconstruction? 19357 sets out the coding and the notes each stage of the procedure needs.
Tracking how patients feel after surgery? Patient satisfaction survey software compares the tools that collect and act on post-treatment feedback.
Frequently asked questions
What is capsular contracture?
Capsular contracture is a complication of breast implant surgery. The fibrous scar tissue capsule that normally forms around the implant tightens and hardens abnormally. That causes breast firmness, shape distortion and, in later grades, pain. It is graded on the Baker scale, from Grade I to Grade IV.
What are the early symptoms of capsular contracture?
The earliest symptom is increased breast firmness on palpation. Patients often notice it as a change in texture compared with the other breast. Mild tightness or pressure around the implant can follow. At Baker Grade II there is usually no visible distortion or pain, which is why consistent monitoring matters.
Is capsular contracture dangerous?
Capsular contracture itself is not life-threatening. Grade III and IV cases cause significant discomfort and distortion, and they almost always need surgical correction. Severe contracture with fluid around the implant warrants urgent evaluation to exclude BIA-ALCL. That is a rare lymphoma associated with textured implants, and it is distinct from capsular contracture.
Can you breastfeed with capsular contracture?
Usually yes. Capsular contracture affects the capsule around the implant rather than the breast tissue or milk ducts. Clinical evidence on breastfeeding outcomes specifically in these patients is limited. Patients should discuss their own anatomy and implant placement with their surgeon, since both can affect milk production.
Does breast implant massage prevent capsular contracture?
The evidence is mixed. Some surgeons recommend displacement massage early after smooth implant placement, and some patients report benefit. Controlled studies have not consistently shown that massage lowers capsular contracture rates. It is generally not recommended for textured implants, so the decision should stay with the surgeon.
What is montelukast (Singulair) used for in capsular contracture?
Montelukast is a leukotriene receptor antagonist approved for asthma and allergic rhinitis. Some surgeons use it off-label as an adjunct for Grade II to III capsular contracture. Small studies suggest it may reduce capsule firmness in some patients. It is not an approved or standard treatment, so any use needs clinical judgment and documented consent.
